Report

Clinical Decision Support Systems Market Size, Share & Trends Analysis - Global Opportunity Analysis And Industry Forecast 2030

  • Publish Date: May,2022
  • Report ID: QI038
  • Page : 200
  • Report Type : PDF (Email)
The global clinical decision support systems market size was US$ 3.0 billion in 2021. The global clinical decision support systems market size is forecast to reach US$ 3.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2022 to 2030.

The Clinical Decision Support System (CDSS) is a computer-based tool that analyses data in electronic health records (EHRs) and provides prompts and recommendations to help health care practitioners follow evidence-based clinical standards at the point of treatment. The CDSS is a computer software meant to be a direct help with clinical decision making for comparing a patient's characteristics can compare to a computerized clinical knowledge base and offering patient-specific estimates or suggestions to the clinicians. CDSSs are now mostly employed at the point of treatment to help clinicians consolidate their expertise by providing information or suggestions. CDSS deployment enhances speedier decision-making, operational data, and workflow efficiency in patient care.

Factors Influencing Market Growth

Technological advances such as EHR systems, business intelligence tools, and big data analytics are helping healthcare providers manage and analyze patient data to make effective clinical decisions. Thus, this factor is forecast to drive the global market.
CDSS provides smooth administration of the number of patients visiting hospitals and healthcare buildings about keeping and managing data entry, storage, and collection. These factors are forecast to fuel the global market growth.
Lack of awareness, data privacy-related concerns, inappropriate handling of the system, and scarcity of skilled professionals may slow down the overall market growth.
Impact Analysis of COVID-19

Clinical decision support software in COVID-19 strengthened and emphasized the worldwide need for consistent healthcare data while reducing the timeline for decision-making due to unmatched stress. Many health care providers have changed their clinical decision support system vendors to help spread desired results quickly. As a result, there was a greater appreciation of clinical decision support systems' value and challenges in quite a few of the world's most important healthcare centers, which are the front-line responders. Thus, the COVID-19 pandemic had a positive impact on the global market.

Regional Insights

North America held dominance in the market in 2021. As a result of the growing demand for healthcare information technology solutions in the medical sector. Increasing technological advancements and the rising importance of providing quality healthcare services fuel the market growth in this region.

The Asia Pacific region is forecast to have lucrative growth in the market over the forecast period. As a result of the rising investments in the healthcare sector in countries such as Australia, China, India, and Japan. In addition, the rising R&D expenditure by the governments of key economies for growing the penetration of information technology in the medical field. Additionally, the growth in the geriatric population is likely to drive regional market growth.

Leading Competitors

The leading prominent companies profiled in the global clinical decision support software market are:

Meditech
Cerner Corporation
Epic Systems Corporation
Allscripts
Mckesson
Philips Healthcare
Wolters Kluwer Health
Hearst Health
Elsevier B.V
IBM
Other Prominent Players
Scope of the Report

The global clinical decision support software market segmentation focuses on Product Type, Deployment Modes, Products, Applications, and Region.

Segmentation based on Product Type

Knowledge-based CDSS
Non-knowledge based CDSS
Segmentation based on Deployment Modes

Web-based
On-premises
Segmentation based on Products

Integrated System
Stand-alone System
Standard-based
Service Model-based
Other Products
Segmentation based on Applications

Medical Diagnosis
Prescription Decision Support
Information Retrieval
Therapy Planning and Assessment
Other Applications
Segmentation based on Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America